Package insert. Prevacid (lansoprazole). Deerfield Park, IL: TAP Holdings Inc., June 1997.
3.
CucchiaraSMinellaRIervolinoCFrancoMTCampanozziAFranceschiMOmeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis. Arch Dis Child1993;69:655–9.
4.
ModlinIMGoldenringJRLawtonGPHuntR. Aspects of the theoretical basis and clinical relevance of low acid states. Am J Gastroenterol1994;89:308–18.
5.
BerlinRG. Omeprazole: Gastrin and gastric endocrine cell data from clinical studies. Dig Dis Sci1991;36:129–36.
6.
FrestonJW. Clinical significance of hypergastrinemia: Relevance to gastrin monitoring during omeprazole therapy. Digestion1992;51(suppl 1):102–14.
7.
NelisGFWesterveldBD. Treatment of resistant reflux oesophagitis in children with omeprazole. Eur J Gastroenterol Hepatol1990;2:215–7.
8.
GunasekaranTSHassallEG. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. J Pediatr1993;123:148–54.
9.
KarjooMKaneR. Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy. Arch Pediatr Adolesc Med1995;149:267–71.
10.
MartinPBImongSMKrischeJNoblettHRSandhuBK. The use of omeprazole for resistant oesophagitis in children. Eur J Pediatr Surg1996;6:195–7.
11.
KatoSEbinaKFujiiKChibaHNakagawaH. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: Endoscopic healing and twenty-four-hour intragastric acidity. J Pediatr1996;128:415–21.
12.
CucchiaraSMinellaRCampanozziASalviaGBorrelliOCiccimarraEEffects of omeprazole on mechanisms of gastroesophageal reflux in childhood. Dig Dis Sci1997;42:293–9.
13.
HassallEShepherdRRadkeMDalvagAJunghardOLundborgPOmeprazole for chronic erosive esophagitis in children: A multicenter study of dose requirement for healing (abstract). Gastroenterology1997; 112(suppl):A425.
14.
De GiacomoCBawaPFranceschiMLuinettiOFioccaR. Omeprazole for severe reflux esophagitis in children. J Pediatr Gastroenterol Nutr1997;24:528–32.
15.
DohilRIsraelDMHassallE. Effective 2-wk therapy for Helicobacter pylori disease in children. Am J Gastroenterol1997;92:244–7.
16.
KatoSTakeyamaJEbinaKNaganumaH. Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children. Pediatrics1997;100:1–5.
17.
BarracloughMTaylorCJ. Twenty-four hour ambulatory gastric and duodenal pH profiles in cystic fibrosis: Effect of duodenal hyperacidity on pancreatic enzyme function and fat absorption. J Pediatr Gastroenterol Nutr1996;23:45–50.
18.
De GiacomoCFioccaRVillaniLLicardiGScottaMSSolciaE. Omeprazole treatment of severe peptic disease associated with antral G cell hyperfunction and hyperpepsinogenemia 1 in an infant. J Pediatr1990;117:989–93.
19.
KinahanTJKhouryAEMcLorieGAChurchillBM. Omeprazole in post-gastrocystoplasty metabolic alkalosis and aciduria. J Urol1992;147:435–7.
20.
DalzellAMSearleJWPatrickMK. Treatment of refractory ulcerative oesophagitis with omeprazole. Arch Dis Child1992;67:641–2.
21.
AllietPRaesMGillisPCallewaertMZimmermannA. Treatment of refractory ulcerative oesophagitis with omeprazole (letter). Arch Dis Child1993;68:526.
22.
MohiuddinMAPursnaniKGGideonRMKatzkaDACastellDO. Can enteric coated omeprazole (OME) granules be orally administered for effective gastric acid suppression? Dig Dis Sci1997;42:715–9.
23.
ChunAHCEasonCJShiHHCavanaughJH. Lansoprazole: An alternative method of administration of a capsule dosage formulation. Clin Therapeut1995;17:441–6.
24.
ChunAHCShiHHAchariRDennisSCavanaughJH. Lansoprazole: Administration of the contents of a capsule dosage formulation through a nasogastric tube. Clin Therapeut1996;18:833–42.
25.
PhillipsJOMetzlerMHPalmieriTLHuckfeldtREDahlNG. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med1996;24:1793–800.
26.
QuerciaRAChengdeFXinchunLChowMSS. Stability of Omeprazole in an extemporaneously prepared oral liquid. Am J Health-Syst Pharm1997;54:1833–6.
